CiteFacts · FDA Drug Shortages · FDA source
Peginterferon alfa-2a Injection
Status
FDA currently lists this ingredient in shortage.
This is nationwide FDA status, not local pharmacy inventory. CiteFacts does not provide medical, treatment, substitution, or dosing advice.
FDA package and manufacturer records
| Company | Presentation | FDA availability field | FDA update |
|---|---|---|---|
| pharmaand GmbH (pharma&) | Pegasys, Injection, 180 ug/.5 mL (NDC 82154-0451-4) | Available | 08/17/2026 |
| pharmaand GmbH (pharma&) | Pegasys, Injection, 180 ug/1 mL (NDC 82154-0449-1) | Unavailable | 08/17/2026 |
Source facts
Grouped generic ingredient: Peginterferon alfa-2a Injection · 2 package records · Latest FDA row update: 08/17/2026
Therapeutic categories: Antiviral
Dosage forms: Injection
Routes: SUBCUTANEOUS
Open FDA source data · JSON · Markdown
FDA is authoritative. Source retrieved 2026-08-22T15:54:11+00:00. Derived grouping is documented in this record's derivations.